Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT04764773 |
| Other study ID # |
Soh-Med-21-02-46 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
May 1, 2020 |
| Est. completion date |
March 31, 2021 |
Study information
| Verified date |
November 2021 |
| Source |
Sohag University |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
Coronavirus disease pandemic has been started in late 2019. Survivors of COVID-19 are
significantly more likely to develop clinical sequelae three months after discharge from the
hospital than those without COVID-19 infection. This is true not only for general and
respiratory symptoms but also for cardiovascular and psychosocial symptoms. This suggests
that these symptoms may indeed be the sequelae of recovery for COVID-19 survivors. So, we
aimed to detect the prevalence and to evaluate the type of symptoms that could persist after
the recovery from COVID19 infection in Sohag governorate, Egypt.
Description:
About one hundred patients who were test positive for SARS-CoV2 and were improved and
discharged from Sohag isolation hospitals and isolation department for COVID19 in Sohag
University hospitals during the period from 15th May, 2020 to 25th July, 2020 will be
included in our study. Patient improvement and discharge criteria include 10 day from
symptoms onset in addition to 3 day free of fever and respiratory symptoms.
Patients with severe complex illness, pregnant or lactating females and patient who refuse to
participate or give complete detailed history will be excluded from the study.
The study protocol will be approved by the scientific Research Ethical committee, Faculty of
Medicine, Sohag University A control group of healthy volunteer who were age and sex matched
to our patient were included
After taken informed consent according to Sohag University Ethical Committee, the baseline
data will be collected from Sohag isolation hospital of COVID19, then the researchers will
perform interviews with all participants through mobile phone. The interview will include:
- Name (Optional)
- Age
- Sex
- Occupation
- Presence of DM, HTN or any chronic illness
- Asking about Smoking
- The date of catching COVID19 infection
- Asking about symptoms of COVID19 infection and duration of each symptom.
- Asking about any residual symptoms as: Fatigue, Myalgia, Arthralgia, Chest pain,
Dyspnea, Dry cough, Productive cough, Sore Throat, Anosmia, Loss of taste sensation,
Nausea, Anorexia, Diarrhea, Redness of the eye, Headache, Confusion and Depression
Statistical analysis:
Data will be analyzed using STATA version 14.2 (Statistical Software: Release 14.2 College
Station, TX: Stata Corp LP). Quantitative data will be represented as mean, standard
deviation, median and range. normally distributed. Qualitative data will be presented as
numbers and percentages. Chi square test will be used for comparison of percentages in
different groups. P value will be considered significant if it was less than 0.05.
